Literature DB >> 33437265

Reliability and validity test of VES-13 and analysis of influencing factors for the vulnerable condition of patients with advanced castration-resistant prostate cancer.

Jia Feng1, Qian Sun2, Jing Li3, Ting-Ting Li4.   

Abstract

OBJECTIVES: To study the relationship between the reliability and validity of VES-13 and the influencing factors of the vulnerable condition of patients with advanced castration-resistant prostate cancer, so as to provide a reference for the health management and nursing of elderly inpatients.
METHODS: By means of convenience sampling, 150 vulnerable patients with advanced castration-resistant prostate cancer who were admitted to the Department of Oncology of the Affiliated Hospital of Hebei University from April 2019 to March 2020 were selected. General data questionnaire, simple mental state checklist, anxiety self-assessment scale, and the vulnerable elders 13 survey (VES-13) were used in this study. The reliability and validity were tested by SPSS 20.0.
RESULTS: For this group of patients, VES-13 Cronbach's α was 0.832, living function was 0.778, body function was 0.846, and the correlation coefficient between items was between 0.401 and 0.823 (P<0.01); the retest reliability was 0.831 (P<0.05), and the correlation coefficient was0.504 (P<0.05). The average time to fill in each scale was 4.53±1.32 Minutes, and general indicators such as economic status and education level were significantly correlated with vulnerability. The clinical indicators of prostate-specific antigen levels, multiple bone metastases, and bone pain were significantly correlated with vulnerability.
CONCLUSION: VES-13 scale had high level of reliability and operability, and was straight forward to understand and use; it can be used as an effective tool for the assessment of vulnerability in patients with advanced prostate cancer. The vulnerability of patients with castration-resistant prostate cancer showed significant correlation with economic status, education level, prostate-specific antigen level, multiple bone metastases, bone pain and other indicators. Nursing staff should pay close attention to the relevant factors of inpatients and give targeted advance intervention measures to facilitate rapid recovery of elderly inpatients. Copyright: © Pakistan Journal of Medical Sciences.

Entities:  

Keywords:  Advanced castration-resistant prostate cancer; Influencing factors; VES-13 scale; Vulnerability

Year:  2021        PMID: 33437265      PMCID: PMC7794163          DOI: 10.12669/pjms.37.1.3095

Source DB:  PubMed          Journal:  Pak J Med Sci        ISSN: 1681-715X            Impact factor:   1.088


  19 in total

1.  Which better predicts mortality among older men, a prostate cancer (PCa) diagnosis or vulnerability on the Vulnerable Elders Survey (VES-13)? A retrospective cohort study.

Authors:  Lisa M Lowenstein; Supriya G Mohile; Heather Hopkins Gil; Chintan Pandya; Joshua Hemmerich; Miriam Rodin; William Dale
Journal:  J Geriatr Oncol       Date:  2016-07-30       Impact factor: 3.599

2.  The vulnerable elders survey-13 predicts hospital complications and mortality in older adults with traumatic injury: a pilot study.

Authors:  Lillian Min; Nitin Ubhayakar; Debra Saliba; Lorraine Kelley-Quon; Eric Morley; Jonathan Hiatt; Henry Cryer; Areti Tillou
Journal:  J Am Geriatr Soc       Date:  2011-06-30       Impact factor: 5.562

3.  A comparison of the CARG tool, the VES-13, and oncologist judgment in predicting grade 3+ toxicities in men undergoing chemotherapy for metastatic prostate cancer.

Authors:  Shabbir M H Alibhai; Salman Aziz; Tharsika Manokumar; Narhari Timilshina; Henriette Breunis
Journal:  J Geriatr Oncol       Date:  2016-10-15       Impact factor: 3.599

4.  Novel approach to therapeutic targeting of castration-resistant prostate cancer.

Authors:  Eswar Shankar; Daniel Franco; Omair Iqbal; Victoria El-Hayek; Sanjay Gupta
Journal:  Med Hypotheses       Date:  2020-02-19       Impact factor: 1.538

5.  Six screening instruments for frailty in older patients qualified for emergency abdominal surgery.

Authors:  Jakub Kenig; Beata Zychiewicz; Urszula Olszewska; Marcin Barczynski; Wojciech Nowak
Journal:  Arch Gerontol Geriatr       Date:  2015-07-06       Impact factor: 3.250

Review 6.  Recent progress in treating advanced prostate cancer.

Authors:  Theodore Gourdin
Journal:  Curr Opin Oncol       Date:  2020-05       Impact factor: 3.645

7.  Is prostate cancer changing?: evolving patterns of metastatic castration-resistant prostate cancer.

Authors:  Stephanie M Doctor; Che-Kai Tsao; James H Godbold; Matthew D Galsky; William K Oh
Journal:  Cancer       Date:  2013-12-30       Impact factor: 6.860

8.  Genetic variant of Interleukin-18 gene is associated with the Frailty Index in the English Longitudinal Study of Ageing.

Authors:  Krisztina Mekli; Alan Marshall; James Nazroo; Bram Vanhoutte; Neil Pendleton
Journal:  Age Ageing       Date:  2015-09-22       Impact factor: 10.668

9.  Chinese Expert Consensus on the Diagnosis and Treatment of Castration-Resistant Prostate Cancer (2019 Update).

Authors:  Yao Zhu; Dingwei Ye
Journal:  Cancer Manag Res       Date:  2020-03-23       Impact factor: 3.989

10.  Spatiotemporal evolution of global population ageing from 1960 to 2017.

Authors:  Junming Li; Xiulan Han; Xiangxue Zhang; Sixian Wang
Journal:  BMC Public Health       Date:  2019-01-30       Impact factor: 3.295

View more
  1 in total

1.  Application of B-ultrasound information image in Renal Puncture Biopsy treatment and Nursing.

Authors:  Linyan Dong; Junhong Li; Mixia Zhao; Jing Ren
Journal:  Pak J Med Sci       Date:  2021       Impact factor: 1.088

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.